Abstract 2093: The Anti-Tumor Activity of IGM-8444, an Agonistic Death Receptor 5 (DR5) IgM Antibody, is Sensitized in Combination with Chemotherapy and Bcl-2 Inhibitors in NHL and AML

The 62nd ASH Annual Meeting and Exposition – December 5-8, 2020


Beatrice T. Wang, Thomas J. Matthew, Ling Wang, Tasnim Kothambawala, Susan E. Calhoun, Eric W. Humke, Angus M. Sinclair, Bruce A. Keyt

IGM Biosciences, Inc., 325 E Middlefield Road, Mountain View, CA 94043

ASH 2020 Abstract 2093 IGM-8444 Wang et al

Posted in publications.